DexCom Gross Profit 2010-2024 | DXCM

DexCom annual/quarterly gross profit history and growth rate from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • DexCom gross profit for the quarter ending December 31, 2024 was $0.656B, a 0.12% decline year-over-year.
  • DexCom gross profit for the twelve months ending December 31, 2024 was $2.438B, a 6.52% increase year-over-year.
  • DexCom annual gross profit for 2024 was $2.438B, a 6.52% increase from 2023.
  • DexCom annual gross profit for 2023 was $2.289B, a 21.55% increase from 2022.
  • DexCom annual gross profit for 2022 was $1.883B, a 12.06% increase from 2021.
DexCom Annual Gross Profit
(Millions of US $)
2024 $2,438
2023 $2,289
2022 $1,883
2021 $1,681
2020 $1,280
2019 $932
2018 $664
2017 $492
2016 $378
2015 $278
2014 $176
2013 $100
2012 $47
2011 $36
2010 $18
2009 $4
DexCom Quarterly Gross Profit
(Millions of US $)
2024-12-31 $656
2024-09-30 $594
2024-06-30 $627
2024-03-31 $562
2023-12-31 $657
2023-09-30 $623
2023-06-30 $546
2023-03-31 $463
2022-12-31 $541
2022-09-30 $494
2022-06-30 $450
2022-03-31 $398
2021-12-31 $473
2021-09-30 $447
2021-06-30 $417
2021-03-31 $344
2020-12-31 $399
2020-09-30 $340
2020-06-30 $284
2020-03-31 $257
2019-12-31 $309
2019-09-30 $247
2019-06-30 $207
2019-03-31 $169
2018-12-31 $223
2018-09-30 $169
2018-06-30 $154
2018-03-31 $119
2017-12-31 $154
2017-09-30 $127
2017-06-30 $118
2017-03-31 $94
2016-12-31 $117
2016-09-30 $101
2016-06-30 $86
2016-03-31 $75
2015-12-31 $91
2015-09-30 $75
2015-06-30 $66
2015-03-31 $47
2014-12-31 $59
2014-09-30 $47
2014-06-30 $40
2014-03-31 $30
2013-12-31 $34
2013-09-30 $28
2013-06-30 $22
2013-03-31 $17
2012-12-31 $18
2012-09-30 $8
2012-06-30 $11
2012-03-31 $9
2011-12-31 $11
2011-09-30 $8
2011-06-30 $12
2011-03-31 $5
2010-12-31 $7
2010-09-30 $3
2010-06-30 $5
2010-03-31 $3
2009-12-31 $4
2009-09-30 $1
2009-06-30 $-1
2009-03-31 $0
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $26.887B $4.033B
DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $171.942B 78.88
Thermo Fisher Scientific (TMO) United States $161.378B 19.56
Alcon (ALC) Switzerland $45.645B 30.34
Edwards Lifesciences (EW) United States $42.050B 27.30
IDEXX Laboratories (IDXX) United States $33.347B 38.56
IQVIA Holdings (IQV) United States $25.374B 14.04
STERIS (STE) Ireland $21.834B 24.97
Mettler-Toledo (MTD) United States $20.944B 24.42
Waters (WAT) United States $19.099B 27.04
SONOVA HOLDING (SONVY) Switzerland $17.304B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $13.878B 14.16
Hologic (HOLX) United States $12.916B 13.94
Sysmex ADR (SSMXY) Japan $11.847B 0.00
Penumbra (PEN) United States $10.729B 96.64
Globus Medical (GMED) United States $9.767B 22.61
Masimo (MASI) United States $8.221B 34.50
Teleflex (TFX) United States $6.004B 9.24
Glaukos (GKOS) United States $5.153B 0.00
Integer Holdings (ITGR) United States $4.081B 22.07
TransMedics (TMDX) United States $2.985B 87.37
PROCEPT BioRobotics (PRCT) United States $2.907B 0.00
Veracyte (VCYT) United States $2.427B 43.86
Nihon Kohden (NHNKY) Japan $2.081B 11.37
LivaNova (LIVN) United Kingdom $1.934B 11.74
Elekta AB (EKTAY) Sweden $1.891B 17.00
Alphatec Holdings (ATEC) United States $1.522B 0.00
Integra LifeSciences Holdings (IART) United States $1.222B 6.18
Pulse Biosciences (PLSE) United States $1.193B 0.00
Tandem Diabetes Care (TNDM) United States $1.122B 0.00
Paragon 28 (FNA) United States $1.099B 0.00
Artivion (AORT) United States $0.979B 91.72
OPKO Health (OPK) United States $0.954B 0.00
AxoGen (AXGN) United States $0.690B 0.00
IRadimed (IRMD) United States $0.658B 34.51
Mesa Laboratories (MLAB) United States $0.609B 13.30
SiBone (SIBN) United States $0.588B 0.00
RxSight (RXST) United States $0.584B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.572B 9.21
OrthoPediatrics (KIDS) United States $0.510B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.508B 0.00
Beta Bionics (BBNX) United States $0.483B 0.00
Treace Medical Concepts (TMCI) United States $0.406B 0.00
Delcath Systems (DCTH) United States $0.389B 0.00
AngioDynamics (ANGO) United States $0.387B 0.00
NeuroPace (NPCE) United States $0.351B 0.00
Pacific Biosciences Of California (PACB) United States $0.348B 0.00
ClearPoint Neuro (CLPT) United States $0.342B 0.00
Tactile Systems Technology (TCMD) United States $0.315B 16.87
Semler Scientific (SMLR) United States $0.312B 6.62
Neuronetics (STIM) United States $0.247B 0.00
Inogen (INGN) United States $0.183B 0.00
Alpha Tau Medical (DRTS) Israel $0.181B 0.00
908 Devices (MASS) United States $0.168B 0.00
Spectral Diagnostics (EDTXF) Canada $0.165B 0.00
LENSAR (LNSR) United States $0.164B 0.00
CVRx (CVRX) United States $0.163B 0.00
Accuray (ARAY) United States $0.152B 0.00
Sight Sciences (SGHT) United States $0.137B 0.00
Lucid Diagnostics (LUCD) United States $0.110B 0.00
KORU Medical Systems (KRMD) United States $0.104B 0.00
Rapid Micro Biosystems (RPID) United States $0.104B 0.00
Anteris Technologies Global (AVR) Australia $0.104B 0.00
Monogram Orthopaedics (MGRM) United States $0.095B 0.00
Microbot Medical (MBOT) United States $0.087B 0.00
Atossa Genetics (ATOS) United States $0.080B 0.00
InspireMD (NSPR) Israel $0.079B 0.00
Sensus Healthcare (SRTS) United States $0.076B 11.48
Hyperfine (HYPR) United States $0.054B 0.00
Positron (POSC) United States $0.051B 0.00
EDAP TMS S.A (EDAP) France $0.051B 0.00
EnVVeno Medical (NVNO) United States $0.043B 0.00
Baird Medical Investment Holdings (BDMD) $0.037B 0.00
Vicarious Surgical (RBOT) United States $0.032B 0.00
Spectral AI (MDAI) United States $0.031B 0.00
DarioHealth (DRIO) United States $0.031B 0.00
Precision Optics (POCI) United States $0.030B 0.00
Envoy Medical (COCH) United States $0.029B 0.00
Adagio Medical Holdings (ADGM) United States $0.027B 0.00
NexGel (NXGL) United States $0.022B 0.00
Accelerate Diagnostics (AXDX) United States $0.014B 0.00
PAVmed (PAVM) United States $0.012B 0.00
Ekso Bionics Holdings (EKSO) United States $0.012B 0.00
Biosig Technologies (BSGM) United States $0.010B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.007B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
WORK Medical Technology Group (WOK) China $0.006B 0.00
Nanovibronix (NAOV) United States $0.005B 0.00
Autonomix Medical (AMIX) United States $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
Check-Cap (CHEK) Israel $0.004B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00